Rank | Gene Set | Z-score |
---|---|---|
1 | sulfate transmembrane transport (GO:1902358) | 6.85066938 |
2 | positive regulation of respiratory burst (GO:0060267) | 6.71230755 |
3 | L-phenylalanine catabolic process (GO:0006559) | 6.35569536 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.35569536 |
5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.28697901 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.14987881 |
7 | L-phenylalanine metabolic process (GO:0006558) | 6.14987881 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 5.74270562 |
9 | sulfate transport (GO:0008272) | 5.60514961 |
10 | axonemal dynein complex assembly (GO:0070286) | 5.56518724 |
11 | oligosaccharide biosynthetic process (GO:0009312) | 5.53483399 |
12 | glomerular filtration (GO:0003094) | 5.40969326 |
13 | sulfur amino acid catabolic process (GO:0000098) | 5.39829127 |
14 | sperm capacitation (GO:0048240) | 5.37526530 |
15 | urea cycle (GO:0000050) | 5.35797203 |
16 | urea metabolic process (GO:0019627) | 5.35797203 |
17 | complement activation, alternative pathway (GO:0006957) | 5.24750604 |
18 | intestinal cholesterol absorption (GO:0030299) | 5.23628841 |
19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21831225 |
20 | indole-containing compound catabolic process (GO:0042436) | 5.21319736 |
21 | indolalkylamine catabolic process (GO:0046218) | 5.21319736 |
22 | tryptophan catabolic process (GO:0006569) | 5.21319736 |
23 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.17056977 |
24 | kynurenine metabolic process (GO:0070189) | 5.10524253 |
25 | cysteine metabolic process (GO:0006534) | 5.09800461 |
26 | regulation of triglyceride catabolic process (GO:0010896) | 5.03807175 |
27 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.01834897 |
28 | alpha-linolenic acid metabolic process (GO:0036109) | 5.00261669 |
29 | bile acid biosynthetic process (GO:0006699) | 4.99426849 |
30 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.95035265 |
31 | renal filtration (GO:0097205) | 4.93394476 |
32 | regulation of cholesterol esterification (GO:0010872) | 4.91587094 |
33 | tryptophan metabolic process (GO:0006568) | 4.89525260 |
34 | nitrogen cycle metabolic process (GO:0071941) | 4.88628389 |
35 | homocysteine metabolic process (GO:0050667) | 4.86024549 |
36 | glyoxylate metabolic process (GO:0046487) | 4.85556472 |
37 | O-glycan processing (GO:0016266) | 4.80585619 |
38 | negative regulation of sterol transport (GO:0032372) | 4.78989275 |
39 | negative regulation of cholesterol transport (GO:0032375) | 4.78989275 |
40 | regulation of protein activation cascade (GO:2000257) | 4.77967596 |
41 | intestinal absorption (GO:0050892) | 4.75660509 |
42 | phospholipid efflux (GO:0033700) | 4.73960353 |
43 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.72652055 |
44 | bile acid and bile salt transport (GO:0015721) | 4.71627995 |
45 | reverse cholesterol transport (GO:0043691) | 4.67364851 |
46 | bile acid metabolic process (GO:0008206) | 4.61954896 |
47 | drug catabolic process (GO:0042737) | 4.60471760 |
48 | regulation of guanylate cyclase activity (GO:0031282) | 4.58414264 |
49 | angiotensin maturation (GO:0002003) | 4.56233512 |
50 | negative regulation of fibrinolysis (GO:0051918) | 4.53508748 |
51 | regulation of complement activation (GO:0030449) | 4.52979683 |
52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.52375937 |
53 | protein-lipid complex remodeling (GO:0034368) | 4.52375937 |
54 | macromolecular complex remodeling (GO:0034367) | 4.52375937 |
55 | cellular glucuronidation (GO:0052695) | 4.51677862 |
56 | serine family amino acid catabolic process (GO:0009071) | 4.50837750 |
57 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.49124212 |
58 | flavonoid metabolic process (GO:0009812) | 4.49070153 |
59 | regulation of respiratory burst (GO:0060263) | 4.47893181 |
60 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.45847457 |
61 | protein carboxylation (GO:0018214) | 4.45847457 |
62 | regulation of cellular extravasation (GO:0002691) | 4.40939276 |
63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.39848561 |
64 | cellular ketone body metabolic process (GO:0046950) | 4.39768041 |
65 | triglyceride homeostasis (GO:0070328) | 4.39645119 |
66 | acylglycerol homeostasis (GO:0055090) | 4.39645119 |
67 | bicarbonate transport (GO:0015701) | 4.36221290 |
68 | regulation of fibrinolysis (GO:0051917) | 4.32963255 |
69 | antibacterial humoral response (GO:0019731) | 4.31143608 |
70 | regulation of bile acid biosynthetic process (GO:0070857) | 4.31057536 |
71 | cholesterol efflux (GO:0033344) | 4.27711240 |
72 | plasma lipoprotein particle assembly (GO:0034377) | 4.21374174 |
73 | lysine metabolic process (GO:0006553) | 4.17218236 |
74 | lysine catabolic process (GO:0006554) | 4.17218236 |
75 | aromatic amino acid family metabolic process (GO:0009072) | 4.15969293 |
76 | amino-acid betaine metabolic process (GO:0006577) | 4.14899508 |
77 | primary alcohol catabolic process (GO:0034310) | 4.14724564 |
78 | antimicrobial humoral response (GO:0019730) | 4.09262654 |
79 | regulation of cholesterol homeostasis (GO:2000188) | 4.07019815 |
80 | ethanol oxidation (GO:0006069) | 4.06282083 |
81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.04156336 |
82 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.04156336 |
83 | positive regulation of pseudopodium assembly (GO:0031274) | 4.02006511 |
84 | alpha-amino acid catabolic process (GO:1901606) | 4.01284472 |
85 | plasma lipoprotein particle clearance (GO:0034381) | 4.00279903 |
86 | uronic acid metabolic process (GO:0006063) | 4.00152109 |
87 | glucuronate metabolic process (GO:0019585) | 4.00152109 |
88 | cellular modified amino acid catabolic process (GO:0042219) | 4.00140409 |
89 | vitamin transmembrane transport (GO:0035461) | 3.98509700 |
90 | glutamate metabolic process (GO:0006536) | 3.97595634 |
91 | cholesterol homeostasis (GO:0042632) | 3.96031077 |
92 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.92293928 |
93 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92142970 |
94 | sterol homeostasis (GO:0055092) | 3.90756270 |
95 | tyrosine metabolic process (GO:0006570) | 3.90482967 |
96 | short-chain fatty acid metabolic process (GO:0046459) | 3.88627160 |
97 | protein-lipid complex assembly (GO:0065005) | 3.82909854 |
98 | intestinal epithelial cell development (GO:0060576) | 3.79202254 |
99 | ketone body metabolic process (GO:1902224) | 3.79129647 |
100 | cellular amino acid catabolic process (GO:0009063) | 3.77467127 |
101 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.77311780 |
102 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.77311780 |
103 | endocrine process (GO:0050886) | 3.77311780 |
104 | phospholipid homeostasis (GO:0055091) | 3.76924547 |
105 | lipoprotein metabolic process (GO:0042157) | 3.75330477 |
106 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.74951872 |
107 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.74951872 |
108 | drug transmembrane transport (GO:0006855) | 3.74705096 |
109 | sulfur compound transport (GO:0072348) | 3.71585244 |
110 | exogenous drug catabolic process (GO:0042738) | 3.69991971 |
111 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.67204695 |
112 | positive regulation of lipid catabolic process (GO:0050996) | 3.66361082 |
113 | desmosome organization (GO:0002934) | 3.66239021 |
114 | indolalkylamine metabolic process (GO:0006586) | 3.65860342 |
115 | regulation of vitamin metabolic process (GO:0030656) | 3.65607957 |
116 | sodium ion homeostasis (GO:0055078) | 3.65380290 |
117 | cilium movement (GO:0003341) | 3.65349091 |
118 | benzene-containing compound metabolic process (GO:0042537) | 3.65145465 |
119 | arginine metabolic process (GO:0006525) | 3.64016089 |
120 | epoxygenase P450 pathway (GO:0019373) | 3.61515470 |
121 | regulation of pseudopodium assembly (GO:0031272) | 3.58935845 |
122 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.58914220 |
123 | coenzyme catabolic process (GO:0009109) | 3.58076582 |
124 | serine family amino acid metabolic process (GO:0009069) | 3.56714377 |
125 | drug metabolic process (GO:0017144) | 3.56702757 |
126 | ethanol metabolic process (GO:0006067) | 3.55234571 |
127 | renal system process involved in regulation of blood volume (GO:0001977) | 3.55143230 |
128 | plasma lipoprotein particle organization (GO:0071827) | 3.54041213 |
129 | imidazole-containing compound metabolic process (GO:0052803) | 3.53689176 |
130 | motile cilium assembly (GO:0044458) | 3.53554608 |
131 | glycine metabolic process (GO:0006544) | 3.52808304 |
132 | low-density lipoprotein particle remodeling (GO:0034374) | 3.52359170 |
133 | amine catabolic process (GO:0009310) | 3.51015652 |
134 | cellular biogenic amine catabolic process (GO:0042402) | 3.51015652 |
135 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.48828492 |
136 | excretion (GO:0007588) | 3.47096606 |
137 | serine family amino acid biosynthetic process (GO:0009070) | 3.46493685 |
138 | negative regulation of lipase activity (GO:0060192) | 3.43279859 |
139 | complement activation, classical pathway (GO:0006958) | 3.42907856 |
140 | response to nitrosative stress (GO:0051409) | 3.39972700 |
141 | carboxylic acid catabolic process (GO:0046395) | 3.37500601 |
142 | organic acid catabolic process (GO:0016054) | 3.37500601 |
143 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.36532798 |
144 | protein-lipid complex subunit organization (GO:0071825) | 3.36051154 |
145 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.35126409 |
146 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33225643 |
147 | aldehyde catabolic process (GO:0046185) | 3.32540624 |
148 | diterpenoid biosynthetic process (GO:0016102) | 3.26978386 |
149 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.25215952 |
150 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.24577156 |
151 | regulation of systemic arterial blood pressure (GO:0003073) | 3.24526748 |
152 | epithelial structure maintenance (GO:0010669) | 3.23456794 |
153 | digestive system process (GO:0022600) | 3.19247485 |
154 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.14000504 |
155 | NADH metabolic process (GO:0006734) | 3.11393052 |
156 | sphingomyelin metabolic process (GO:0006684) | 3.08462483 |
157 | negative regulation of myotube differentiation (GO:0010832) | 3.05211536 |
158 | regulation of intracellular pH (GO:0051453) | 3.00764735 |
159 | protein O-linked glycosylation (GO:0006493) | 3.00461485 |
160 | primary alcohol metabolic process (GO:0034308) | 2.99342197 |
161 | multicellular organismal water homeostasis (GO:0050891) | 2.97300053 |
162 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.95469384 |
163 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.94038811 |
164 | drug transport (GO:0015893) | 2.90183641 |
165 | eosinophil chemotaxis (GO:0048245) | 2.86570634 |
166 | lipid translocation (GO:0034204) | 2.86374716 |
167 | phospholipid translocation (GO:0045332) | 2.86374716 |
168 | hormone catabolic process (GO:0042447) | 2.85547015 |
169 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.83513509 |
170 | regulation of cGMP biosynthetic process (GO:0030826) | 2.82392582 |
171 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.81391277 |
172 | actin filament depolymerization (GO:0030042) | 2.81338493 |
173 | epithelial cilium movement (GO:0003351) | 2.79388547 |
174 | cGMP-mediated signaling (GO:0019934) | 2.78603608 |
175 | digestion (GO:0007586) | 2.77810981 |
176 | monovalent inorganic cation homeostasis (GO:0055067) | 2.76212653 |
177 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74110037 |
178 | complement activation (GO:0006956) | 2.73953748 |
179 | regulation of cellular pH (GO:0030641) | 2.70593707 |
180 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.70016200 |
181 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.69583531 |
182 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.68923002 |
183 | transepithelial transport (GO:0070633) | 2.68675253 |
184 | glycosylceramide metabolic process (GO:0006677) | 2.64733966 |
185 | lipoprotein transport (GO:0042953) | 2.64674767 |
186 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.64075047 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.44620896 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.54930944 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.05886118 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.92564877 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78995370 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.37625259 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.22206411 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.63928122 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99935194 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.64546819 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.49904795 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24619446 |
13 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.18993405 |
14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.06245251 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05396215 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4412874 |
17 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82550131 |
18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79597224 |
19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77056144 |
20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.75448191 |
21 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.67053055 |
22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65338014 |
23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65254566 |
24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.52561900 |
25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51777051 |
26 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.50218610 |
27 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.46302121 |
28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34862785 |
29 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31324587 |
30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30294163 |
31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29143923 |
32 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27578094 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24890244 |
34 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23562165 |
35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21614877 |
36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15987520 |
37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15432602 |
38 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15377805 |
39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11065832 |
40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11024867 |
41 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10403573 |
42 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.08114445 |
43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07510149 |
44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05101009 |
45 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04430072 |
46 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03707720 |
47 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01899726 |
48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00931710 |
49 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00285108 |
50 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00165030 |
51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98306419 |
52 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98121886 |
53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97801270 |
54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97776662 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97015162 |
56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94432582 |
57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94378716 |
58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94215271 |
59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94144168 |
60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92930483 |
61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90268950 |
62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87959950 |
63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87091615 |
64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85644543 |
65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84764672 |
66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84262231 |
67 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83799566 |
68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83067196 |
69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82780264 |
70 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82000846 |
71 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.81262311 |
72 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81004248 |
73 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80246281 |
74 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80217737 |
75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79589609 |
76 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79111635 |
77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78830519 |
78 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78826608 |
79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78791427 |
80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77985726 |
81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77771019 |
82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76873242 |
83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76536377 |
84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76442389 |
85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.75714887 |
86 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75597449 |
87 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.75413426 |
88 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.74509447 |
89 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74442833 |
90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74292574 |
91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74292574 |
92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73554873 |
93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.73526358 |
94 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72838505 |
95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.72232693 |
96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71893327 |
97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71851100 |
98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71836233 |
99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71481070 |
100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70450741 |
101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69254007 |
102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69254007 |
103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68823454 |
104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68320486 |
105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67095082 |
106 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.66924316 |
107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66692345 |
108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64679104 |
109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64534237 |
110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.62792005 |
111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61516865 |
112 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.61115068 |
113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60179045 |
114 | ATF3_27146783_Chip-Seq_COLON_Human | 0.59114859 |
115 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.58798605 |
116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58256424 |
117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.57973916 |
118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56970538 |
119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56922418 |
120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.56621739 |
121 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.56530333 |
122 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.56466791 |
123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.56226812 |
124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56145994 |
125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.55826419 |
126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.55021288 |
127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.54286741 |
128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.52627055 |
129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52310033 |
130 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51856973 |
131 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50970246 |
132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.50223061 |
133 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.50096402 |
134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.49266570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.02968482 |
2 | MP0002139_abnormal_hepatobiliary_system | 7.49269410 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.14368880 |
4 | MP0005365_abnormal_bile_salt | 5.33279505 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.85338525 |
6 | MP0003252_abnormal_bile_duct | 4.51761132 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.74011180 |
8 | MP0001666_abnormal_nutrient_absorption | 3.56341638 |
9 | MP0010329_abnormal_lipoprotein_level | 3.33296442 |
10 | MP0009840_abnormal_foam_cell | 3.25316276 |
11 | MP0010352_gastrointestinal_tract_polyps | 2.69546755 |
12 | * MP0001664_abnormal_digestion | 2.55006591 |
13 | MP0005083_abnormal_biliary_tract | 2.51874832 |
14 | MP0005332_abnormal_amino_acid | 2.47343502 |
15 | MP0003183_abnormal_peptide_metabolism | 2.30547796 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.26248990 |
17 | MP0000490_abnormal_crypts_of | 2.16569586 |
18 | MP0003195_calcinosis | 2.10248427 |
19 | MP0010234_abnormal_vibrissa_follicle | 2.00610544 |
20 | MP0000465_gastrointestinal_hemorrhage | 1.95719782 |
21 | MP0000609_abnormal_liver_physiology | 1.95486353 |
22 | MP0003191_abnormal_cellular_cholesterol | 1.86817140 |
23 | MP0002118_abnormal_lipid_homeostasis | 1.86257026 |
24 | MP0004264_abnormal_extraembryonic_tissu | 1.83042393 |
25 | MP0003300_gastrointestinal_ulcer | 1.82021786 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.79774473 |
27 | MP0005670_abnormal_white_adipose | 1.74883253 |
28 | MP0003868_abnormal_feces_composition | 1.70187225 |
29 | MP0005319_abnormal_enzyme/_coenzyme | 1.67644051 |
30 | MP0005409_darkened_coat_color | 1.66032805 |
31 | MP0003724_increased_susceptibility_to | 1.60500263 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.59951263 |
33 | MP0002132_abnormal_respiratory_system | 1.57087146 |
34 | MP0002277_abnormal_respiratory_mucosa | 1.54886167 |
35 | MP0002166_altered_tumor_susceptibility | 1.41951744 |
36 | MP0000678_abnormal_parathyroid_gland | 1.41112779 |
37 | MP0009643_abnormal_urine_homeostasis | 1.38486714 |
38 | MP0003303_peritoneal_inflammation | 1.34903573 |
39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33611117 |
40 | MP0005451_abnormal_body_composition | 1.33264446 |
41 | MP0009697_abnormal_copulation | 1.30650698 |
42 | MP0009780_abnormal_chondrocyte_physiolo | 1.28006775 |
43 | MP0000566_synostosis | 1.27148429 |
44 | MP0010678_abnormal_skin_adnexa | 1.23717238 |
45 | MP0002254_reproductive_system_inflammat | 1.23696890 |
46 | MP0005165_increased_susceptibility_to | 1.17944835 |
47 | MP0005310_abnormal_salivary_gland | 1.16186072 |
48 | * MP0001764_abnormal_homeostasis | 1.14376840 |
49 | MP0008004_abnormal_stomach_pH | 1.12960625 |
50 | MP0004858_abnormal_nervous_system | 1.10082436 |
51 | MP0005636_abnormal_mineral_homeostasis | 1.06491387 |
52 | MP0003866_abnormal_defecation | 1.06037199 |
53 | MP0000462_abnormal_digestive_system | 1.01909546 |
54 | MP0001188_hyperpigmentation | 0.99909634 |
55 | MP0002822_catalepsy | 0.99561547 |
56 | MP0002006_tumorigenesis | 0.99104186 |
57 | MP0010155_abnormal_intestine_physiology | 0.98662313 |
58 | MP0000598_abnormal_liver_morphology | 0.98624001 |
59 | MP0005647_abnormal_sex_gland | 0.96966111 |
60 | MP0002896_abnormal_bone_mineralization | 0.96661044 |
61 | MP0000604_amyloidosis | 0.94860798 |
62 | MP0009764_decreased_sensitivity_to | 0.94100629 |
63 | MP0000230_abnormal_systemic_arterial | 0.91133970 |
64 | MP0002796_impaired_skin_barrier | 0.90373507 |
65 | MP0009785_altered_susceptibility_to | 0.89583575 |
66 | MP0003656_abnormal_erythrocyte_physiolo | 0.88194104 |
67 | MP0003718_maternal_effect | 0.86140208 |
68 | MP0001663_abnormal_digestive_system | 0.85429934 |
69 | MP0003186_abnormal_redox_activity | 0.84779267 |
70 | MP0003011_delayed_dark_adaptation | 0.82432383 |
71 | MP0005084_abnormal_gallbladder_morpholo | 0.82339501 |
72 | MP0008469_abnormal_protein_level | 0.81727246 |
73 | MP0009642_abnormal_blood_homeostasis | 0.81025569 |
74 | MP0005381_digestive/alimentary_phenotyp | 0.80991402 |
75 | * MP0005025_abnormal_response_to | 0.78882497 |
76 | MP0009765_abnormal_xenobiotic_induced | 0.78662851 |
77 | MP0006082_CNS_inflammation | 0.78090886 |
78 | MP0002876_abnormal_thyroid_physiology | 0.77796898 |
79 | MP0000470_abnormal_stomach_morphology | 0.77296114 |
80 | MP0009763_increased_sensitivity_to | 0.77210073 |
81 | MP0003045_fibrosis | 0.76603153 |
82 | MP0001881_abnormal_mammary_gland | 0.74257574 |
83 | MP0001485_abnormal_pinna_reflex | 0.73775139 |
84 | MP0005023_abnormal_wound_healing | 0.72811857 |
85 | MP0009053_abnormal_anal_canal | 0.72126465 |
86 | MP0002928_abnormal_bile_duct | 0.71278148 |
87 | MP0001849_ear_inflammation | 0.69942098 |
88 | MP0004043_abnormal_pH_regulation | 0.69313056 |
89 | * MP0005376_homeostasis/metabolism_phenot | 0.68689376 |
90 | MP0006036_abnormal_mitochondrial_physio | 0.67166849 |
91 | MP0001501_abnormal_sleep_pattern | 0.66886935 |
92 | MP0005408_hypopigmentation | 0.66623439 |
93 | MP0005448_abnormal_energy_balance | 0.66085016 |
94 | MP0001533_abnormal_skeleton_physiology | 0.65904362 |
95 | MP0000681_abnormal_thyroid_gland | 0.64880343 |
96 | MP0005166_decreased_susceptibility_to | 0.64116833 |
97 | MP0005266_abnormal_metabolism | 0.64094601 |
98 | MP0000249_abnormal_blood_vessel | 0.63848284 |
99 | * MP0000477_abnormal_intestine_morphology | 0.63687535 |
100 | MP0010386_abnormal_urinary_bladder | 0.63604418 |
101 | MP0001756_abnormal_urination | 0.63550630 |
102 | MP0004484_altered_response_of | 0.63352091 |
103 | MP0002078_abnormal_glucose_homeostasis | 0.63195351 |
104 | MP0008872_abnormal_physiological_respon | 0.62504887 |
105 | MP0000538_abnormal_urinary_bladder | 0.62409203 |
106 | MP0005220_abnormal_exocrine_pancreas | 0.61041268 |
107 | MP0003453_abnormal_keratinocyte_physiol | 0.60410157 |
108 | MP0003879_abnormal_hair_cell | 0.59196559 |
109 | MP0003436_decreased_susceptibility_to | 0.59151597 |
110 | MP0005501_abnormal_skin_physiology | 0.58776159 |
111 | MP0005395_other_phenotype | 0.58748959 |
112 | * MP0005387_immune_system_phenotype | 0.58552217 |
113 | * MP0001790_abnormal_immune_system | 0.58552217 |
114 | MP0002136_abnormal_kidney_physiology | 0.58223856 |
115 | MP0002098_abnormal_vibrissa_morphology | 0.58158816 |
116 | MP0000627_abnormal_mammary_gland | 0.57622047 |
117 | MP0001873_stomach_inflammation | 0.57514745 |
118 | MP0001765_abnormal_ion_homeostasis | 0.57132999 |
119 | MP0002998_abnormal_bone_remodeling | 0.54474642 |
120 | MP0002009_preneoplasia | 0.52700472 |
121 | MP0002971_abnormal_brown_adipose | 0.52675360 |
122 | MP0004782_abnormal_surfactant_physiolog | 0.51675689 |
123 | MP0005334_abnormal_fat_pad | 0.51620195 |
124 | MP0000537_abnormal_urethra_morphology | 0.48859796 |
125 | MP0004947_skin_inflammation | 0.47795532 |
126 | MP0005167_abnormal_blood-brain_barrier | 0.47475925 |
127 | MP0010368_abnormal_lymphatic_system | 0.46171580 |
128 | MP0003329_amyloid_beta_deposits | 0.45658089 |
129 | MP0000467_abnormal_esophagus_morphology | 0.45215810 |
130 | MP0009384_cardiac_valve_regurgitation | 0.45120839 |
131 | MP0008873_increased_physiological_sensi | 0.44809746 |
132 | MP0004883_abnormal_blood_vessel | 0.41963932 |
133 | MP0009379_abnormal_foot_pigmentation | 0.41758689 |
134 | MP0001243_abnormal_dermal_layer | 0.41547412 |
135 | MP0005464_abnormal_platelet_physiology | 0.41390937 |
136 | MP0003638_abnormal_response/metabolism_ | 0.41379400 |
137 | MP0004147_increased_porphyrin_level | 0.41303437 |
138 | MP0003075_altered_response_to | 0.40787947 |
139 | MP0006035_abnormal_mitochondrial_morpho | 0.40689677 |
140 | MP0002060_abnormal_skin_morphology | 0.40219837 |
141 | MP0005666_abnormal_adipose_tissue | 0.39456814 |
142 | MP0004130_abnormal_muscle_cell | 0.38896000 |
143 | MP0001845_abnormal_inflammatory_respons | 0.38597441 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperactive renin-angiotensin system (HP:0000841) | 9.89311272 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.86434237 |
3 | Hypobetalipoproteinemia (HP:0003563) | 6.70914191 |
4 | Deep venous thrombosis (HP:0002625) | 6.34989121 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30798677 |
6 | Decreased circulating renin level (HP:0003351) | 6.24546215 |
7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.20642137 |
8 | Abnormality of renin-angiotensin system (HP:0000847) | 6.00399980 |
9 | Flat acetabular roof (HP:0003180) | 5.96118955 |
10 | Xanthomatosis (HP:0000991) | 5.81125615 |
11 | Metabolic alkalosis (HP:0200114) | 5.54107241 |
12 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.45882775 |
13 | Prolonged partial thromboplastin time (HP:0003645) | 5.41556163 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.36250401 |
15 | Abnormality of chloride homeostasis (HP:0011422) | 5.34309134 |
16 | Hyperaldosteronism (HP:0000859) | 4.98950211 |
17 | Chronic bronchitis (HP:0004469) | 4.96281169 |
18 | Hypolipoproteinemia (HP:0010981) | 4.68862317 |
19 | Rhinitis (HP:0012384) | 4.61990087 |
20 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.57944018 |
21 | Fat malabsorption (HP:0002630) | 4.51543269 |
22 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.50314200 |
23 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.50314200 |
24 | Hyperglycinuria (HP:0003108) | 4.47620489 |
25 | Conjugated hyperbilirubinemia (HP:0002908) | 4.43150990 |
26 | Complement deficiency (HP:0004431) | 4.42037004 |
27 | Hyperammonemia (HP:0001987) | 4.41708360 |
28 | Hyperlipoproteinemia (HP:0010980) | 4.38957333 |
29 | Abnormal ciliary motility (HP:0012262) | 4.38543664 |
30 | Absent/shortened dynein arms (HP:0200106) | 4.32530478 |
31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.32530478 |
32 | Epidermoid cyst (HP:0200040) | 4.25591523 |
33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.19623632 |
34 | Abnormality of glycine metabolism (HP:0010895) | 4.19623632 |
35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14732262 |
36 | Bronchiectasis (HP:0002110) | 4.05818755 |
37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05790770 |
38 | Hyperglycinemia (HP:0002154) | 3.98484824 |
39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.88127339 |
40 | Neonatal short-limb short stature (HP:0008921) | 3.87922289 |
41 | Joint hemorrhage (HP:0005261) | 3.87745829 |
42 | Abnormality of the nasal mucosa (HP:0000433) | 3.85756182 |
43 | Hyponatremia (HP:0002902) | 3.84378280 |
44 | Hypoglycemic coma (HP:0001325) | 3.80209639 |
45 | Abnormality of the common coagulation pathway (HP:0010990) | 3.74404355 |
46 | Ketosis (HP:0001946) | 3.72550772 |
47 | Flattened epiphyses (HP:0003071) | 3.68099621 |
48 | Nasal polyposis (HP:0100582) | 3.62129065 |
49 | Hypoalphalipoproteinemia (HP:0003233) | 3.57119118 |
50 | Acanthocytosis (HP:0001927) | 3.54541604 |
51 | Hydroxyprolinuria (HP:0003080) | 3.45971863 |
52 | Abnormality of proline metabolism (HP:0010907) | 3.45971863 |
53 | Hypercholesterolemia (HP:0003124) | 3.44995656 |
54 | Abnormality of methionine metabolism (HP:0010901) | 3.39453011 |
55 | Flat capital femoral epiphysis (HP:0003370) | 3.39208688 |
56 | Spinal cord compression (HP:0002176) | 3.38474696 |
57 | Malnutrition (HP:0004395) | 3.32750405 |
58 | Ileus (HP:0002595) | 3.31661681 |
59 | Hyperkalemia (HP:0002153) | 3.27619811 |
60 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.24023008 |
61 | Abnormality of complement system (HP:0005339) | 3.23524296 |
62 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.21671800 |
63 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.12481598 |
64 | Abnormality of the intrinsic pathway (HP:0010989) | 3.12473190 |
65 | Hyperbilirubinemia (HP:0002904) | 3.11739833 |
66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10527380 |
67 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05094839 |
68 | Bronchitis (HP:0012387) | 3.01577628 |
69 | Hypokalemia (HP:0002900) | 3.00621277 |
70 | Visceral angiomatosis (HP:0100761) | 3.00024974 |
71 | Dicarboxylic aciduria (HP:0003215) | 2.95713141 |
72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95713141 |
73 | Abnormality of purine metabolism (HP:0004352) | 2.95630755 |
74 | Steatorrhea (HP:0002570) | 2.94024887 |
75 | Abnormality of sodium homeostasis (HP:0010931) | 2.93894610 |
76 | Metabolic acidosis (HP:0001942) | 2.90413278 |
77 | Abnormality of potassium homeostasis (HP:0011042) | 2.86751388 |
78 | Myocardial infarction (HP:0001658) | 2.79191038 |
79 | Ketoacidosis (HP:0001993) | 2.78832503 |
80 | Vascular calcification (HP:0004934) | 2.77768880 |
81 | Abnormal vertebral ossification (HP:0100569) | 2.74588628 |
82 | Abnormal biliary tract morphology (HP:0012440) | 2.73652358 |
83 | Hemangiomatosis (HP:0007461) | 2.70313136 |
84 | Adrenal overactivity (HP:0002717) | 2.66346125 |
85 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.64947149 |
86 | Vertebral hypoplasia (HP:0008417) | 2.64947149 |
87 | Spontaneous abortion (HP:0005268) | 2.64499395 |
88 | Breech presentation (HP:0001623) | 2.58952294 |
89 | Hepatocellular carcinoma (HP:0001402) | 2.57376728 |
90 | Skin nodule (HP:0200036) | 2.55860302 |
91 | Poikilocytosis (HP:0004447) | 2.53967679 |
92 | Lethargy (HP:0001254) | 2.53448504 |
93 | Delayed CNS myelination (HP:0002188) | 2.47767074 |
94 | Right ventricular cardiomyopathy (HP:0011663) | 2.46660654 |
95 | Cardiovascular calcification (HP:0011915) | 2.46453742 |
96 | Abnormality of serum amino acid levels (HP:0003112) | 2.45875274 |
97 | Chronic diarrhea (HP:0002028) | 2.45313928 |
98 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.43864151 |
99 | Villous atrophy (HP:0011473) | 2.43864151 |
100 | Vertebral clefting (HP:0008428) | 2.40370076 |
101 | Esophageal varix (HP:0002040) | 2.40281237 |
102 | Recurrent sinusitis (HP:0011108) | 2.40190633 |
103 | Hypoglycemic seizures (HP:0002173) | 2.39230507 |
104 | Gout (HP:0001997) | 2.37631089 |
105 | Pancreatitis (HP:0001733) | 2.35790329 |
106 | Dehydration (HP:0001944) | 2.32440526 |
107 | Male infertility (HP:0003251) | 2.31647386 |
108 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.29771612 |
109 | Systemic lupus erythematosus (HP:0002725) | 2.27152297 |
110 | Large earlobe (HP:0009748) | 2.25557941 |
111 | Alkalosis (HP:0001948) | 2.25290476 |
112 | Late onset (HP:0003584) | 2.21596292 |
113 | Spastic diplegia (HP:0001264) | 2.21293701 |
114 | Rectal prolapse (HP:0002035) | 2.21063480 |
115 | Neonatal onset (HP:0003623) | 2.19293309 |
116 | Abnormal gallbladder morphology (HP:0012437) | 2.19220908 |
117 | Abnormality of urine glucose concentration (HP:0011016) | 2.18733837 |
118 | Glycosuria (HP:0003076) | 2.18733837 |
119 | Abnormal cartilage morphology (HP:0002763) | 2.18120210 |
120 | Renal salt wasting (HP:0000127) | 2.16689588 |
121 | Abnormality of vitamin metabolism (HP:0100508) | 2.16438932 |
122 | Hypochromic microcytic anemia (HP:0004840) | 2.15988893 |
123 | Cholelithiasis (HP:0001081) | 2.15475994 |
124 | Renal tubular acidosis (HP:0001947) | 2.13182287 |
125 | Sensorimotor neuropathy (HP:0007141) | 2.13151011 |
126 | Chronic otitis media (HP:0000389) | 2.12883910 |
127 | Abnormal tarsal ossification (HP:0008369) | 2.12706529 |
128 | Irritability (HP:0000737) | 2.12498561 |
129 | Chronic sinusitis (HP:0011109) | 2.12488899 |
130 | Glomerulonephritis (HP:0000099) | 2.12445771 |
131 | Cholecystitis (HP:0001082) | 2.11457765 |
132 | Abnormal gallbladder physiology (HP:0012438) | 2.11457765 |
133 | Hypotension (HP:0002615) | 2.10138081 |
134 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.07404329 |
135 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.05145398 |
136 | Syncope (HP:0001279) | 2.04362651 |
137 | Cerebral edema (HP:0002181) | 2.02472582 |
138 | Generalized aminoaciduria (HP:0002909) | 2.02454387 |
139 | Amyloidosis (HP:0011034) | 2.02167964 |
140 | Congenital sensorineural hearing impairment (HP:0008527) | 2.01621228 |
141 | Vomiting (HP:0002013) | 2.01325504 |
142 | Abdominal distention (HP:0003270) | 1.99499362 |
143 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.98854247 |
144 | Symptomatic seizures (HP:0011145) | 1.98240202 |
145 | Eczematoid dermatitis (HP:0000976) | 1.97725256 |
146 | Irregular epiphyses (HP:0010582) | 1.97101741 |
147 | Abnormality of carpal bone ossification (HP:0006257) | 1.96849202 |
148 | Rickets (HP:0002748) | 1.93909117 |
149 | Hemorrhage of the eye (HP:0011885) | 1.93590707 |
150 | Ventricular fibrillation (HP:0001663) | 1.93548586 |
151 | Hoarse voice (HP:0001609) | 1.92627054 |
152 | Hip contracture (HP:0003273) | 1.91586531 |
153 | Nephritis (HP:0000123) | 1.90799683 |
154 | Proximal tubulopathy (HP:0000114) | 1.90614190 |
155 | Pili torti (HP:0003777) | 1.90544635 |
156 | Abnormality of vitamin B metabolism (HP:0004340) | 1.90265006 |
157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90050109 |
158 | Infertility (HP:0000789) | 1.89496370 |
159 | Gingival bleeding (HP:0000225) | 1.89202969 |
160 | Menorrhagia (HP:0000132) | 1.86490172 |
161 | Recurrent otitis media (HP:0000403) | 1.85542823 |
162 | Abnormality of the gallbladder (HP:0005264) | 1.84390993 |
163 | Hip dysplasia (HP:0001385) | 1.83532254 |
164 | Hyperparathyroidism (HP:0000843) | 1.83104653 |
165 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82706327 |
166 | Reticulocytosis (HP:0001923) | 1.82705856 |
167 | Severe short stature (HP:0003510) | 1.80321266 |
168 | Pigmentary retinal degeneration (HP:0001146) | 1.79578909 |
169 | Protuberant abdomen (HP:0001538) | 1.78935864 |
170 | Increased mean platelet volume (HP:0011877) | 1.78543256 |
171 | Nephrolithiasis (HP:0000787) | 1.77815720 |
172 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75949570 |
173 | Short middle phalanx of finger (HP:0005819) | 1.71606131 |
174 | Biliary tract neoplasm (HP:0100574) | 1.70596702 |
175 | Abnormal foot bone ossification (HP:0010675) | 1.69162294 |
176 | Recurrent bronchitis (HP:0002837) | 1.67718944 |
177 | Palpitations (HP:0001962) | 1.66216369 |
178 | Interstitial pulmonary disease (HP:0006530) | 1.65582779 |
179 | Widely patent fontanelles and sutures (HP:0004492) | 1.65499542 |
180 | Focal segmental glomerulosclerosis (HP:0000097) | 1.65038264 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 4.95602530 |
2 | NUAK1 | 4.73190207 |
3 | BCKDK | 3.74258037 |
4 | FRK | 3.69701957 |
5 | MST4 | 3.67346851 |
6 | MST1R | 3.57231021 |
7 | STK38L | 3.39174907 |
8 | PIK3CA | 3.29395157 |
9 | ERN1 | 3.10108917 |
10 | MAP3K7 | 3.00158212 |
11 | LMTK2 | 2.95337576 |
12 | SIK1 | 2.62280439 |
13 | FGFR4 | 2.60962210 |
14 | TAOK3 | 2.39662049 |
15 | MAP2K2 | 2.22284820 |
16 | DMPK | 2.18000223 |
17 | STK24 | 2.10084648 |
18 | PKN2 | 2.04817439 |
19 | EPHB2 | 1.89896431 |
20 | PTK6 | 1.82876088 |
21 | ERBB4 | 1.65662024 |
22 | INSRR | 1.61053521 |
23 | PDK2 | 1.43568667 |
24 | GRK6 | 1.42590571 |
25 | LATS1 | 1.41483304 |
26 | PRKG2 | 1.38481777 |
27 | TRIB3 | 1.35993039 |
28 | EPHA2 | 1.34635461 |
29 | RIPK1 | 1.31734970 |
30 | RAF1 | 1.31213755 |
31 | ERBB2 | 1.28667099 |
32 | PIK3CG | 1.27018488 |
33 | MAP3K12 | 1.26212363 |
34 | FGFR3 | 1.23236750 |
35 | TEC | 1.22413224 |
36 | MET | 1.20607949 |
37 | MAPK11 | 1.16275309 |
38 | TYK2 | 1.16275115 |
39 | MAP3K10 | 1.14839845 |
40 | NLK | 1.12959464 |
41 | STK39 | 1.06118170 |
42 | MAPKAPK3 | 0.98149126 |
43 | MAP3K2 | 0.97911172 |
44 | STK38 | 0.95853995 |
45 | PRKAA2 | 0.95239855 |
46 | MAP2K1 | 0.94897220 |
47 | TBK1 | 0.94895833 |
48 | MAP2K4 | 0.91632748 |
49 | PDPK1 | 0.90628440 |
50 | MAP2K6 | 0.87139853 |
51 | MYLK | 0.86038946 |
52 | AKT3 | 0.84140702 |
53 | EEF2K | 0.82772013 |
54 | CSK | 0.81319551 |
55 | FLT3 | 0.77785479 |
56 | TAOK1 | 0.77755707 |
57 | DDR2 | 0.74948590 |
58 | EPHB1 | 0.74192096 |
59 | CDC42BPA | 0.74017034 |
60 | SMG1 | 0.73114508 |
61 | NME1 | 0.67536584 |
62 | OXSR1 | 0.67395450 |
63 | KDR | 0.67075387 |
64 | PDK1 | 0.66826221 |
65 | FER | 0.66039757 |
66 | BCR | 0.65597121 |
67 | ABL2 | 0.65114630 |
68 | IRAK1 | 0.64349329 |
69 | PTK2 | 0.62903960 |
70 | DAPK2 | 0.61488970 |
71 | JAK2 | 0.60798404 |
72 | PRKCQ | 0.60039849 |
73 | RIPK4 | 0.59052638 |
74 | BMPR2 | 0.58994999 |
75 | WNK4 | 0.57649843 |
76 | CDK6 | 0.55498112 |
77 | PRKAA1 | 0.50849226 |
78 | MAP3K3 | 0.50650922 |
79 | CDK4 | 0.48556891 |
80 | PRKCZ | 0.48384709 |
81 | GRK1 | 0.46973335 |
82 | ILK | 0.46328590 |
83 | NEK9 | 0.45991881 |
84 | ZAP70 | 0.45324034 |
85 | JAK1 | 0.45147776 |
86 | PRKACG | 0.44994465 |
87 | FGFR2 | 0.44724389 |
88 | PAK4 | 0.43751074 |
89 | RET | 0.43689206 |
90 | CAMK2G | 0.41050001 |
91 | CAMK2D | 0.40526225 |
92 | PBK | 0.40045165 |
93 | SRC | 0.39994955 |
94 | MATK | 0.39709904 |
95 | MAPK4 | 0.39673346 |
96 | GSK3A | 0.39531320 |
97 | MAPKAPK2 | 0.38633717 |
98 | DYRK1B | 0.38489007 |
99 | TRPM7 | 0.38437976 |
100 | MAP3K11 | 0.38146650 |
101 | IKBKE | 0.38028342 |
102 | CASK | 0.36850965 |
103 | YES1 | 0.34538048 |
104 | FYN | 0.34165972 |
105 | PRKCI | 0.33530018 |
106 | PRPF4B | 0.33237434 |
107 | RPS6KA2 | 0.33158939 |
108 | TESK2 | 0.32804931 |
109 | MAPK15 | 0.32034477 |
110 | BMX | 0.31738210 |
111 | PRKCD | 0.31509628 |
112 | IRAK3 | 0.30977960 |
113 | PKN1 | 0.30578066 |
114 | MAP3K1 | 0.29402461 |
115 | MAP3K14 | 0.28580073 |
116 | PRKCA | 0.28127128 |
117 | ERBB3 | 0.27999636 |
118 | ROCK1 | 0.27763929 |
119 | STK3 | 0.27664462 |
120 | KSR2 | 0.27107592 |
121 | TNIK | 0.25720187 |
122 | IGF1R | 0.25632413 |
123 | NEK6 | 0.25500739 |
124 | PRKG1 | 0.25004682 |
125 | CAMK1D | 0.24878575 |
126 | TESK1 | 0.23281406 |
127 | PDGFRB | 0.22407418 |
128 | CSNK1A1 | 0.22360015 |
129 | PRKACB | 0.22348138 |
130 | ICK | 0.21919501 |
131 | LRRK2 | 0.21018384 |
132 | PAK3 | 0.20809488 |
133 | EPHA3 | 0.20771880 |
134 | MAP2K3 | 0.20374701 |
135 | PDK3 | 0.19827922 |
136 | PDK4 | 0.19827922 |
137 | MELK | 0.18718963 |
138 | MAPK7 | 0.18429038 |
139 | BRSK2 | 0.16608798 |
140 | SGK1 | 0.14567941 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.76920486 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.54581657 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52875718 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.82033724 |
5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62070574 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.59600683 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57374341 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35976658 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35723209 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.28931915 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27223583 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.25547244 |
13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22882838 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22429241 |
15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.16098381 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14442198 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13189921 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.07433779 |
19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06861703 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88580220 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86742824 |
22 | Peroxisome_Homo sapiens_hsa04146 | 1.82472251 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80905493 |
24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80063622 |
25 | Bile secretion_Homo sapiens_hsa04976 | 1.79257710 |
26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78213815 |
27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72554237 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71965443 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65118962 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63995618 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63621642 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61736489 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61103498 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57444460 |
35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51831763 |
36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45127790 |
37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43233433 |
38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40660686 |
39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36686189 |
40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36599281 |
41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35339830 |
42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.33865268 |
43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29723572 |
44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28769912 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27420554 |
46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24718176 |
47 | ABC transporters_Homo sapiens_hsa02010 | 1.21139232 |
48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15670361 |
49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14439450 |
50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14413300 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10057059 |
52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08231124 |
53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02869630 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01537826 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00375471 |
56 | Asthma_Homo sapiens_hsa05310 | 0.99712804 |
57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90452068 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89654077 |
59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86592982 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85705347 |
61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85659336 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84899833 |
63 | Allograft rejection_Homo sapiens_hsa05330 | 0.84615376 |
64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83046682 |
65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79116286 |
66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79103843 |
67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78652284 |
68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75492942 |
69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75328232 |
70 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73822876 |
71 | Mineral absorption_Homo sapiens_hsa04978 | 0.72043037 |
72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68929096 |
73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67677836 |
74 | Lysine degradation_Homo sapiens_hsa00310 | 0.67396499 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63768962 |
76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62690082 |
77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60123256 |
78 | Renin secretion_Homo sapiens_hsa04924 | 0.56963135 |
79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56888960 |
80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55883209 |
81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52932709 |
82 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49503382 |
83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49120953 |
84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46546689 |
85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42701885 |
86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40776167 |
87 | Pertussis_Homo sapiens_hsa05133 | 0.40520917 |
88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38734962 |
89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37443802 |
90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35565878 |
91 | Salivary secretion_Homo sapiens_hsa04970 | 0.30017258 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30013507 |
93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28859021 |
94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27725495 |
95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27589925 |
96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.26788484 |
97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24474274 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.21727621 |
99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21157654 |
100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.21070450 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.18315823 |
102 | Amoebiasis_Homo sapiens_hsa05146 | 0.16698983 |
103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.15472052 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15106430 |
105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.14145771 |
106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13603767 |
107 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13237191 |
108 | Salmonella infection_Homo sapiens_hsa05132 | 0.11842183 |
109 | Influenza A_Homo sapiens_hsa05164 | 0.11149780 |
110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08680886 |
111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08212924 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06470583 |
113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06001034 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.05086752 |
115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03357193 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02980994 |
117 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1594325 |
118 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1514251 |
119 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1508670 |
120 | Bladder cancer_Homo sapiens_hsa05219 | -0.1409408 |
121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1298144 |
122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0995767 |
123 | Hepatitis C_Homo sapiens_hsa05160 | -0.0912364 |
124 | Tight junction_Homo sapiens_hsa04530 | -0.0849346 |
125 | Adherens junction_Homo sapiens_hsa04520 | -0.0368293 |
126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0324769 |
127 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0149600 |
128 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0085496 |
129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0082691 |